Clinical trial
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen…
NCT00498901 · University of Washington, Other · Terminated
Key facts
| NCT number | NCT00498901 |
|---|---|
| Title | Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer |
| Official title | Phase II Pilot of Aromatase Inhibitor Therapy With Femara® (Letrozole) and Ovarian Suppression in Premenopausal Estrogen Receptor Positive Women With Stage IV Carcinoma of the Breast |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | goserelin, letrozole, leuprolide acetate, conventional surgery |
| Enrollment | 1 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Jul 11, 2007 |
| Last update posted | May 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: